Magical Trade
Wednesday, March 22, 2023
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Magical Trade
No Result
View All Result
Home Trade News

Johnson & Johnson Stock Jumps on Reports It Plans to Split In Two

by
November 12, 2021
in Trade News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter
Text size

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California

Mark Ralston/AFP via Getty Images


Johnson & Johnson

announced plans on Friday to split from its consumer health division, spelling the end of the last great pharmaceutical conglomerate.

Johnson & Johnson (ticker: JNJ) shares were up on the news, which comes two months before a planned CEO transition, in which longtime Johnson & Johnson executive Joaquin Duato is slated to replace Alex Gorsky in the top post.

RELATED POSTS

Exxon vs. Chevron? Goldman Sachs reveals its favorite — and other energy picks

Euro pushes higher as ECB chief Lagarde says inflation is still too high

Johnson & Johnson said that the split will take 18 to 24 months. The consumer health division, which the company said is expected to generate $15 billion in revenue this year, will become a new publicly traded company, selling big-name brands home health brands like Band-Aid, Tylenol, and Listerine.

The pharmaceutical and medical devices divisions, which the company expects to generate revenue of $77 billion this year, will stay behind as a separate company, selling a range of treatments and devices, from balloons used in sinus procedures to bladder cancer therapies. Johnson & Johnson has chosen not to split those two business segments.

Today, with a market value of $432.5 billion, Johnson & Johnson is the largest pharmaceutical company in the world. Johnson & Johnson says that the stay-behind pharmaceutical and medical device business will remain the biggest pharmaceutical company in the world.

Johnson & Johnson stock was up 4.9% in premarket trading Friday, while

S&P 500
futures had advanced 0.2% and

Dow Jones Industrial Average
futures had risen 0.2%.

Johnson & Johnson has become something of an anachronism in recent years, as its competitors have shed their consumer health divisions one after another.


Pfizer

(PFE) handed its consumer health business to


GlaxoSmithKline

(GSK) in 2019; Glaxo is planning on spinning off the combined business soon.

The market has taken time to warm up to those deals.

Johnson & Johnson would be the third company with plans to break up that were revealed this week. General Electric (GE) said it will break itself up into three parts, while


Toshiba

has said it plans to split up as well.

Write to Ben Levisohn at ben.levisohn@barrons.com

ShareTweetPin

Related Posts

Exxon vs. Chevron? Goldman Sachs reveals its favorite — and other energy picks

by
March 22, 2023
0

Energy stocks dropped last week as oil prices fell to a 15-year low , with the banking crisis roiling markets....

Euro pushes higher as ECB chief Lagarde says inflation is still too high

by
March 22, 2023
0

European Central Bank (ECB) President Christine Lagarde announces a new monetary policy decision. Frederick Florin | Afp | Getty Images...

Gold prices could notch an all-time high soon — and stay there

by
March 22, 2023
0

In this article CSG.N-CH Follow your favorite stocksCREATE FREE ACCOUNT Investors have been flocking to gold and Treasurys as bank...

UK inflation rate breaks 3-month stretch of declines with surprise rise to 10.4%

by
March 22, 2023
0

U.K. inflation data paints a picture of the British economy. Bloomberg / Contributor / Getty Images U.K. inflation unexpectedly jumped...

Virgin Orbit returning ‘small’ team from unpaid pause on Thursday to prep for next rocket launch

by
March 22, 2023
0

In this article VORB Follow your favorite stocksCREATE FREE ACCOUNT Virgin Orbit flew its modified Boeing 747 airplane "Cosmic Girl"...

Next Post

Stocks making the biggest moves premarket: Johnson & Johnson, Rivian, Lordstown and more

J&J plans to split into two companies, separating consumer products and pharmaceutical businesses

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • Fund manager believes FAANG is dead — says now it’s all about MANTA

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Bank of America names its top global tech stocks — including one it says has upside of 100%

    0 shares
    Share 0 Tweet 0
  • Josh Brown says Nvidia’s potential is ‘scary’ ahead of a potential AI boom

    0 shares
    Share 0 Tweet 0
  • This idiot-proof portfolio has beaten traditional stocks and bonds over 50 years

    0 shares
    Share 0 Tweet 0
  • Home
  • Trade News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.magicaltrade.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.magicaltrade.net